BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33471415)

  • 1. Implications for the colorectal surgeon following the 100 000 Genomes Project.
    McDermott FD; Newton K; Beggs AD; Clark SK
    Colorectal Dis; 2021 May; 23(5):1049-1058. PubMed ID: 33471415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing strategies for Lynch syndrome in people with endometrial cancer: systematic reviews and economic evaluation.
    Stinton C; Jordan M; Fraser H; Auguste P; Court R; Al-Khudairy L; Madan J; Grammatopoulos D; Taylor-Phillips S
    Health Technol Assess; 2021 Jun; 25(42):1-216. PubMed ID: 34169821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Colorectal Carcinoma with Suspected Lynch Syndrome: A Multidisciplinary Algorithm].
    Schneider R; Schneider C; Büttner R; Reinacher-Schick A; Tannapfel A; Fürst A; Rüschoff J; Jakobeit C; Royer-Pokora B; Möslein G
    Zentralbl Chir; 2015 Dec; 140(6):591-9. PubMed ID: 25372301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in genetic technologies result in improved diagnosis of mismatch repair deficiency in colorectal and endometrial cancers.
    Evans DG; Lalloo F; Ryan NA; Bowers N; Green K; Woodward ER; Clancy T; Bolton J; McVey RJ; Wallace AJ; Newton K; Hill J; McMahon R; Crosbie EJ
    J Med Genet; 2022 Apr; 59(4):328-334. PubMed ID: 33452216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the utility and acceptability of Faecal immunochemical testing (FIT) as a novel intervention for the improvement of colorectal Cancer (CRC) surveillance in individuals with lynch syndrome (FIT for lynch study): a single-arm, prospective, multi-centre, non-randomised study.
    Lincoln A; Benton S; Piggott C; North BV; Rigney J; Young C; Quirke P; Sasieni P; Monahan KJ
    BMC Cancer; 2022 Nov; 22(1):1144. PubMed ID: 36344941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementing universal Lynch syndrome screening (IMPULSS): protocol for a multi-site study to identify strategies to implement, adapt, and sustain genomic medicine programs in different organizational contexts.
    Rahm AK; Cragun D; Hunter JE; Epstein MM; Lowery J; Lu CY; Pawloski PA; Sharaf RN; Liang SY; Burnett-Hartman AN; Gudgeon JM; Hao J; Snyder S; Gogoi R; Ladd I; Williams MS
    BMC Health Serv Res; 2018 Oct; 18(1):824. PubMed ID: 30376847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary non-polyposis colorectal cancer/Lynch syndrome in three dimensions.
    Kravochuck SE; Church JM
    ANZ J Surg; 2017 Dec; 87(12):1006-1010. PubMed ID: 26990828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multilevel research and the challenges of implementing genomic medicine.
    Khoury MJ; Coates RJ; Fennell ML; Glasgow RE; Scheuner MT; Schully SD; Williams MS; Clauser SB
    J Natl Cancer Inst Monogr; 2012 May; 2012(44):112-20. PubMed ID: 22623603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lynch syndrome: implications for the surgeon.
    Scaife CL; Rodriguez-Bigas MA
    Clin Colorectal Cancer; 2003 Aug; 3(2):92-8. PubMed ID: 12952564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
    Carethers JM; Stoffel EM
    World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hereditary nonpolyposis colorectal carcinoma (HNPCC): surgical aspects].
    Möslein G
    Praxis (Bern 1994); 2001 Mar; 90(12):483-9. PubMed ID: 11324307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of next generation genomic sequencing for disease diagnosis: design of a randomized controlled trial in patients with colorectal cancer/polyposis syndromes.
    Gallego CJ; Bennette CS; Heagerty P; Comstock B; Horike-Pyne M; Hisama F; Amendola LM; Bennett RL; Dorschner MO; Tarczy-Hornoch P; Grady WM; Fullerton SM; Trinidad SB; Regier DA; Nickerson DA; Burke W; Patrick DL; Jarvik GP; Veenstra DL
    Contemp Clin Trials; 2014 Sep; 39(1):1-8. PubMed ID: 24997220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of yield and experiences of age-related molecular investigation for heritable and nonheritable causes of mismatch repair deficient colorectal cancer to identify Lynch syndrome.
    Vos JR; Fakkert IE; Spruijt L; Willems RW; Langenveld S; Mensenkamp AR; Leter EM; Nagtegaal ID; Ligtenberg MJL; Hoogerbrugge N;
    Int J Cancer; 2020 Oct; 147(8):2150-2158. PubMed ID: 32510614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic immunohistochemical screening for Lynch syndrome in colorectal cancer: a single centre experience of 486 patients.
    Zumstein V; Vinzens F; Zettl A; Heinimann K; Koeberle D; von Flüe M; Bolli M
    Swiss Med Wkly; 2016; 146():w14315. PubMed ID: 27152634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsatellite instability and colorectal cancer.
    Geiersbach KB; Samowitz WS
    Arch Pathol Lab Med; 2011 Oct; 135(10):1269-77. PubMed ID: 21970482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis.
    Ladabaum U; Wang G; Terdiman J; Blanco A; Kuppermann M; Boland CR; Ford J; Elkin E; Phillips KA
    Ann Intern Med; 2011 Jul; 155(2):69-79. PubMed ID: 21768580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the role of public health in implementation of genomics-related recommendations: a case study of hereditary cancers using the CDC Science Impact Framework.
    Green RF; Ari M; Kolor K; Dotson WD; Bowen S; Habarta N; Rodriguez JL; Richardson LC; Khoury MJ
    Genet Med; 2019 Jan; 21(1):28-37. PubMed ID: 29907802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementing screening for Lynch syndrome among patients with newly diagnosed colorectal cancer: summary of a public health/clinical collaborative meeting.
    Bellcross CA; Bedrosian SR; Daniels E; Duquette D; Hampel H; Jasperson K; Joseph DA; Kaye C; Lubin I; Meyer LJ; Reyes M; Scheuner MT; Schully SD; Senter L; Stewart SL; St Pierre J; Westman J; Wise P; Yang VW; Khoury MJ
    Genet Med; 2012 Jan; 14(1):152-62. PubMed ID: 22237445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rise of the genome and personalised medicine.
    Brittain HK; Scott R; Thomas E
    Clin Med (Lond); 2017 Dec; 17(6):545-551. PubMed ID: 29196356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).
    Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Nakagawa H; Sotamaa K; Prior TW; Westman J; Panescu J; Fix D; Lockman J; Comeras I; de la Chapelle A
    N Engl J Med; 2005 May; 352(18):1851-60. PubMed ID: 15872200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.